As of September 2024, AstraZeneca has a market cap of $271.65B. This makes AstraZeneca the world's 36th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $193.62B | -7.28% |
2023 | $208.81B | -0.66% |
2022 | $210.20B | 16.39% |
2021 | $180.59B | 16.52% |
2020 | $154.99B | 0.26% |
2019 | $154.58B | 31.28% |
2018 | $117.75B | 9.45% |
2017 | $107.58B | 27.01% |
2016 | $84.70B | -19.53% |
2015 | $105.26B | -3.52% |
2014 | $109.10B | 18.56% |
2013 | $92.02B | 25.55% |
2012 | $73.29B | 2.16% |
2011 | $71.74B | 0.22% |
2010 | $71.59B | -1.62% |
2009 | $72.76B | 14.38% |
2008 | $63.62B | -4.16% |
2007 | $66.38B | -20.02% |
2006 | $83.00B | 10.16% |
2005 | $75.34B | 33.52% |
2004 | $56.43B | -24.76% |
2003 | $75.00B | 37.83% |
2002 | $54.41B | -24.68% |
2001 | $72.24B | -9.51% |
2000 | $79.83B | 23.32% |
1999 | $64.73B | -6.95% |
1998 | $69.57B | 24.67% |
1997 | $55.81B | 28.57% |
1996 | $43.40B | 43.88% |
1995 | $30.17B | 42.04% |
1994 | $21.24B | 10.31% |
1993 | $19.25B | -85.77% |
1970 | $135.33B | 0.00% |
1969 | $135.33B | - |